Sanofi SA
PAR:SAN
Sanofi SA
Cash from Operating Activities
Sanofi SA
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sanofi SA
PAR:SAN
|
Cash from Operating Activities
€10.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
4%
|
|
Ipsen SA
PAR:IPN
|
Cash from Operating Activities
€879.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
17%
|
|
Vetoquinol SA
PAR:VETO
|
Cash from Operating Activities
€106m
|
CAGR 3-Years
11%
|
CAGR 5-Years
24%
|
CAGR 10-Years
14%
|
|
Virbac SA
PAR:VIRP
|
Cash from Operating Activities
€126.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
Boiron SA
PAR:BOI
|
Cash from Operating Activities
€33.9m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-11%
|
|
Medincell SA
PAR:MEDCL
|
Cash from Operating Activities
-€21m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
See Also
What is Sanofi SA's Cash from Operating Activities?
Cash from Operating Activities
10.3B
EUR
Based on the financial report for Dec 31, 2023, Sanofi SA's Cash from Operating Activities amounts to 10.3B EUR.
What is Sanofi SA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
4%
Over the last year, the Cash from Operating Activities growth was -3%. The average annual Cash from Operating Activities growth rates for Sanofi SA have been 11% over the past three years , 13% over the past five years , and 4% over the past ten years .